Clinical Study of Pregnant Women With COVID-19

NCT04701944 | Unknown

• 1 other identifier: 7794
• Study Type: observational
• Target: 54
• Locations: 1 country
• Sites: 1

Brief Summary

A new pandemic, COVID-19, has spread rapidly around the world. She does not spare pregnant women. Little is known about the clinical course of pregnant women infected with COVID-19. As of April 1, 2020, six case series and one case report for a total of 61 pregnancies affected by COVID-19, all from the pandemic epicenter in China, except for one state case report -Unis, have been published. These preliminary reports suggest that pregnant women are not more seriously affected than the general population and show a certain gap with what we have observed in the care of pregnant women at HUS. For these reasons, additional information, especially from parts of the world other than China, as the severity of the disease can vary from country to country, is urgently needed to determine whether pregnant women with the disease of COVID-19 will not present with severe pneumonia to COVID-19.

Conditions

Covid-19

Keywords

COVID-19; COVID-19 Pandemic; Sars-cov-2; Pregnant women

Outcome Measures

Primary Outcomes (1)

• A retrospective review of the medical records of pregnant women with COVID-19 at the University Hospitals of Strasbourg

  Files analysed retrospectively from March 01, 2020 to April 30, 2020 will be examined]

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Pregnant woman suffering from a confirmed or suspected COVID-19 infection

You may qualify if:

• Adult woman (≥18 years old)
• Pregnant woman
• Suffering from a confirmed or suspected COVID-19 infection
• Patient who has been medically treated at Strasbourg University Hospitals as well as for his newborn baby, between 03/01/2020 and April 30, 2020
• Woman having given, after information, her agreement for the reuse of her data for the purposes of this research

You may not qualify if:

• Patient who expressed her opposition to participating in the study
• Patient under guardianship or under guardianship
• Patient under legal protection

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Department of Gynecology-Obstetrics and Fertility - Strasbourg University Hospitals

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Philippe DERUELLE, MD, PhD

  Department of Gynecology-Obstetrics and Fertility - Strasbourg University Hospitals

  STUDY DIRECTOR

Central Study Contacts

Philippe DERUELLE, MD, PhD

CONTACT

33 3 88 12 84 55; philippe.deruelle@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR

CONTACT

33 3 88 11 66 90; said.chayer@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 7, 2021
• First Posted: January 8, 2021
• Study Start: April 21, 2020
• Primary Completion: April 21, 2021
• Study Completion: April 21, 2021
• Last Updated: January 8, 2021

Record last verified: 2021-01

Locations

FR (1)